Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) Low P/S

Simply Wall St.09-27

When you see that almost half of the companies in the Medical Equipment industry in Hong Kong have price-to-sales ratios (or "P/S") above 3.1x, Suzhou Basecare Medical Corporation Limited (HKG:2170) ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2470074473?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401","is_english":true,"pubTime":"2024-09-27 10:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2470074473","market":"us","top_or_hot":-1,"title":"Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) Low P/S","media":"Simply Wall St.","content":"<div>\n<p>When you see that almost half of the companies in the Medical Equipment industry in Hong Kong have price-to-sales ratios (or \"P/S\") above 3.1x, Suzhou Basecare Medical Corporation Limited (HKG:2170) ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-2170/suzhou-basecare-medical-shares/news/lacklustre-performance-is-driving-suzhou-basecare-medical-co-1\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) Low P/S</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) Low P/S\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-27 10:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/healthcare/hkg-2170/suzhou-basecare-medical-shares/news/lacklustre-performance-is-driving-suzhou-basecare-medical-co-1><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>When you see that almost half of the companies in the Medical Equipment industry in Hong Kong have price-to-sales ratios (or \"P/S\") above 3.1x, Suzhou Basecare Medical Corporation Limited (HKG:2170) ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-2170/suzhou-basecare-medical-shares/news/lacklustre-performance-is-driving-suzhou-basecare-medical-co-1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物医药B类股","start_time":0,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2170/suzhou-basecare-medical-shares/news/lacklustre-performance-is-driving-suzhou-basecare-medical-co-1","article_id":"2470074473","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2470074473","pubTimestamp":1727405316,"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"When you see that almost half of the companies in the Medical Equipment industry in Hong Kong have price-to-sales...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1574":"生物医药B类股","BK1597":"三胎概念","02170":"贝康医疗-B","BK1222":"医疗保健用品"},"translate_title":"业绩低迷导致苏州百思医疗有限公司（HKG：2170）市盈率较低","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02170":1},"content_text":"When you see that almost half of the companies in the Medical Equipment industry in Hong Kong have price-to-sales ratios (or \"P/S\") above 3.1x, Suzhou Basecare Medical Corporation Limited (HKG:2170) looks to be giving off some buy signals with its 1.5x P/S ratio.   However, the P/S might be low for a reason and it requires further investigation to determine if it's justified.     Check out our latest analysis for Suzhou Basecare Medical SEHK:2170 Price to Sales Ratio vs Industry September 27th 2024 What Does Suzhou Basecare Medical's P/S Mean For Shareholders?  With revenue growth that's superior to most other companies of late, Suzhou Basecare Medical has been doing relatively well.   One possibility is that the P/S ratio is low because investors think this strong revenue performance might be less impressive moving forward.  If the company manages to stay the course, then investors should be rewarded with a share price that matches its revenue figures.      Want the full picture on analyst estimates for the company? Then our free report on Suzhou Basecare Medical will help you uncover what's on the horizon.   What Are Revenue Growth Metrics Telling Us About The Low P/S?   In order to justify its P/S ratio, Suzhou Basecare Medical would need to produce sluggish growth that's trailing the industry.   Retrospectively, the last year delivered an exceptional 57% gain to the company's top line.   The latest three year period has also seen an excellent 149% overall rise in revenue, aided by its short-term performance.  Accordingly, shareholders would have definitely welcomed those medium-term rates of revenue growth.     Turning to the outlook, the next year should generate growth of 17%  as estimated by the only analyst watching the company.  That's shaping up to be materially lower than the 32% growth forecast for the broader industry.  With this in consideration, its clear as to why Suzhou Basecare Medical's P/S is falling short industry peers.  Apparently many shareholders weren't comfortable holding on while the company is potentially eyeing a less prosperous future.    The Key Takeaway  While the price-to-sales ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of revenue expectations.  We've established that Suzhou Basecare Medical maintains its low P/S on the weakness of its forecast growth being lower than the wider industry, as expected.  At this stage investors feel the potential for an improvement in revenue isn't great enough to justify a higher P/S ratio.  It's hard to see the share price rising strongly in the near future under these circumstances.      We don't want to rain on the parade too much, but we did also find 2 warning signs for Suzhou Basecare Medical that you need to be mindful of.   Of course, profitable companies with a history of great earnings growth are generally safer bets. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly. New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2470074473"}